Skip to main content
Top
Published in: CEN Case Reports 2/2017

Open Access 01-11-2017 | Case report

A case of perirenal extramedullary hematopoiesis in a patient with primary myelofibrosis

Authors: Kentaro Imai, Tomonori Aoi, Hiroki Kitai, Nobuhide Endo, Masahiko Fujino, Shizunori Ichida

Published in: CEN Case Reports | Issue 2/2017

Login to get access

Abstract

Extramedullary hematopoiesis (EMH) is hematopoiesis in organs outside the bone marrow and most frequently occurs in the liver, spleen, and lymph nodes. We report a case of perirenal EMH revealed by kidney biopsy in a patient with primary myelofibrosis. We observed only bilateral kidney enlargement with plain computed tomography (CT) and ultrasonography before obtaining a renal biopsy. We obtained a percutaneous biopsy from the lower pole of the left kidney using ultrasonographic guidance. Ultrasonography just after the renal biopsy revealed no bleeding around the kidney. However, early the next morning, the patient developed severe hemorrhagic shock. Contrast-enhanced CT at that time revealed a massive hematoma in the left posterior perirenal space and bilateral abnormalities of the perirenal soft tissues. In patients with primary myelofibrosis, if plain CT shows an abnormal renal enlargement, EMH should be considered. In addition, a contrast-enhanced CT should be obtained before performing a percutaneous renal biopsy to assess for the possibility of perirenal EMH in these patients.
Literature
1.
go back to reference Georgiades CS, Neyman EG, Francis IR, Sneider MB, Fishman EK. Typical and atypical presentations of extramedullary hemopoiesis. Am J Roentgenol. 2002;179:1239–43.CrossRef Georgiades CS, Neyman EG, Francis IR, Sneider MB, Fishman EK. Typical and atypical presentations of extramedullary hemopoiesis. Am J Roentgenol. 2002;179:1239–43.CrossRef
2.
go back to reference Koch CA, Li CY, Mesa RA, Tefferi A. Nonhepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment. Mayo Clin Proc. 2003;78:1223–33.CrossRef Koch CA, Li CY, Mesa RA, Tefferi A. Nonhepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment. Mayo Clin Proc. 2003;78:1223–33.CrossRef
3.
go back to reference Said SM, Leung N, Sethi S, Cornell LD, Fidler ME, Grande JP, Herrmann S, Tefferi A, D’Agati VD, Nasr SH. Myeloproliferative neoplasms cause glomerulopathy. Kidney Int. 2011;80:753–9.CrossRef Said SM, Leung N, Sethi S, Cornell LD, Fidler ME, Grande JP, Herrmann S, Tefferi A, D’Agati VD, Nasr SH. Myeloproliferative neoplasms cause glomerulopathy. Kidney Int. 2011;80:753–9.CrossRef
4.
go back to reference Kreuziger LB, Carlson M, Mesa H, Gupta P. Perinephric extramedullary haematopoiesis in primary myelofibrosis. Br J Haematol. 2012;157:157.CrossRef Kreuziger LB, Carlson M, Mesa H, Gupta P. Perinephric extramedullary haematopoiesis in primary myelofibrosis. Br J Haematol. 2012;157:157.CrossRef
5.
go back to reference Chen G, Ali R, Shuldberg MM, Bastani B, Brink DS. Extramedullary hematopoiesis in renal allograft. Clin Kidney J. 2013;6:491–4.CrossRef Chen G, Ali R, Shuldberg MM, Bastani B, Brink DS. Extramedullary hematopoiesis in renal allograft. Clin Kidney J. 2013;6:491–4.CrossRef
6.
go back to reference Alexander MP, Nasr SH, Kurtin PJ, Casey ET, Hernandez LP, Fidler ME, Sethi S, Cornell LD. Renal extramedullary hematopoiesis: interstitial and glomerular pathology. Mod Pathol. 2015;28:1574–83.CrossRef Alexander MP, Nasr SH, Kurtin PJ, Casey ET, Hernandez LP, Fidler ME, Sethi S, Cornell LD. Renal extramedullary hematopoiesis: interstitial and glomerular pathology. Mod Pathol. 2015;28:1574–83.CrossRef
7.
go back to reference Kakite S, Tanabe Y, Kinoshita F, Harada H, Ogawa T. Clinical usefulness of In-111 chloride and Tc-99m Sn colloid scintigraphy in the diagnosis of intrathoracic extramedullary hematopoiesis. Ann Nucl Med. 2005;19:317–20.CrossRef Kakite S, Tanabe Y, Kinoshita F, Harada H, Ogawa T. Clinical usefulness of In-111 chloride and Tc-99m Sn colloid scintigraphy in the diagnosis of intrathoracic extramedullary hematopoiesis. Ann Nucl Med. 2005;19:317–20.CrossRef
8.
go back to reference Choi H, David CL, Katz RL, Podoloff DA. Case 69: extramedullary hematopoiesis. Radiology. 2004;231:52–6.CrossRef Choi H, David CL, Katz RL, Podoloff DA. Case 69: extramedullary hematopoiesis. Radiology. 2004;231:52–6.CrossRef
9.
go back to reference Khandelwal A, Gupta A, Khandelwal K. Perinephric extramedullary hematopoiesis. Kidney Int. 2012;81:326.CrossRef Khandelwal A, Gupta A, Khandelwal K. Perinephric extramedullary hematopoiesis. Kidney Int. 2012;81:326.CrossRef
10.
go back to reference Cheng YN, Ting IW. Perirenal extramedullary hematopoiesis. N Engl J Med. 2017;376:2470.CrossRef Cheng YN, Ting IW. Perirenal extramedullary hematopoiesis. N Engl J Med. 2017;376:2470.CrossRef
11.
go back to reference Westphalen A, Yeh B, Qayyum A, Hari A, Coakley FV. Differential diagnosis of perinephric masses on CT and MRI. Am J Roentgenol. 2004;183:1697–702.CrossRef Westphalen A, Yeh B, Qayyum A, Hari A, Coakley FV. Differential diagnosis of perinephric masses on CT and MRI. Am J Roentgenol. 2004;183:1697–702.CrossRef
12.
go back to reference Wasylkowski LC, Pérez EM, Buitrago DFC, Rodríguez GV, Sevillano CEG. Uncommon renal masses: perirenal extramedullary hematopoiesis and multiple lymphangiomatosis with a perirenal lymphangioma. Arch Esp Urol. 2014;67(10):848–52. Wasylkowski LC, Pérez EM, Buitrago DFC, Rodríguez GV, Sevillano CEG. Uncommon renal masses: perirenal extramedullary hematopoiesis and multiple lymphangiomatosis with a perirenal lymphangioma. Arch Esp Urol. 2014;67(10):848–52.
13.
go back to reference Ablett MJ, Vosylius P. Perirenal extramedullary hematopoiesis in myelofibrosis demonstrated on computed tomography. Br J Haematol. 2004;124:406.CrossRef Ablett MJ, Vosylius P. Perirenal extramedullary hematopoiesis in myelofibrosis demonstrated on computed tomography. Br J Haematol. 2004;124:406.CrossRef
Metadata
Title
A case of perirenal extramedullary hematopoiesis in a patient with primary myelofibrosis
Authors
Kentaro Imai
Tomonori Aoi
Hiroki Kitai
Nobuhide Endo
Masahiko Fujino
Shizunori Ichida
Publication date
01-11-2017
Publisher
Springer Singapore
Published in
CEN Case Reports / Issue 2/2017
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-017-0274-1

Other articles of this Issue 2/2017

CEN Case Reports 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine